Trials / Unknown
UnknownNCT04553003
Glucocorticosteroid Therapy on Drug-induced Liver Injury: a Prospective Non-randomized Concurrent Control Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Li Yang · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of glucocorticosteroid for treatment of drug-induced liver injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glucocorticoids+hepatoprotectant | Participants received glucocorticoids (0.4mg/kg/d po.) and hepatoprotectant for 7 days. |
| DRUG | hepatoprotectant | Participants received hepatoprotectants (i.v.gtt.) for 7 days. |
Timeline
- Start date
- 2020-08-01
- Primary completion
- 2025-04-01
- Completion
- 2025-04-01
- First posted
- 2020-09-17
- Last updated
- 2022-04-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04553003. Inclusion in this directory is not an endorsement.